posted on 2021-01-07, 18:06authored byHao Wang, Yongyan Song, Yuxin Wu, Virender Kumar, Ram I Mahato, Qiaozhu Su
MicroRNAs (miRNAs)
are noncoding small RNAs that regulate various pathophysiological cellular processes.
Here we reported that expression of the miR-378 family was significantly induced
by metabolic inflammatory inducers, a high-fructose diet, and inflammatory
cytokine TNFa. Hepatic miRNA profiling revealed that expression of miR-378a
was highly upregulated which, in turn, targeted the 3’-UTR of PPARa mRNA, impaired mitochondrial fatty acid b-oxidation and induced mitochondrial and ER stress. More
importantly, the upregulated miR-378a can directly bind to and activate the dsRNA-dependent
protein kinase R (PKR) to sustain the metabolic stress. In vivo, genetic depletion of miR-378a prevented PKR activation, ameliorated
inflammatory stress and insulin resistance. Counterbalancing the upregulated miR-378a
using nanoparticles encapsulated with an anti-miR-378a oligonucleotide restored
PPARa activity, inhibited PKR activation and ER stress, and
improved insulin sensitivity in the fructose-fed mice. Conclusion: Our study delineated a novel mechanism of miRNA-378a in
the pathogenesis of metabolic inflammation and insulin resistance through targeting
metabolic signaling at both mRNA (e.g., PPARa) and protein (e.g., PKR) molecules. This novel
finding of functional interaction between miRNAs (e.g., miR-378a) and cellular RNA
binding protein(s) (e.g., PKR) is biologically significant as it greatly
broadens the potential targets of miRNAs in cellular pathophysiological processes.
Funding
This work was supported by a grant from British Heart Foundation (UK) (PG/19/86134788) and a grant from National Institutes of Health (NIH, USA) (P20 GM104320-01A) to Q. Su.